Published in Arch Phys Med Rehabil on March 01, 1982
Treatments for chronic pain in persons with spinal cord injury: A survey study. J Spinal Cord Med (2006) 1.33
[Respiratory failure due to delta-9-tetrahydrocannabinol in a tetraplegic patient]. Schmerz (2006) 0.75
A simple index of Crohn's-disease activity. Lancet (1980) 11.12
Effects of increased dietary fibre on intestinal transit. Lancet (1973) 3.49
Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. Lancet (1973) 3.18
Organic and functional disorders in 2000 gastroenterology outpatients. Lancet (1983) 2.78
Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet (1987) 2.13
The effect of wheat bran on intestinal transit. Gut (1975) 2.10
Measurement of gastric emptying time with a gamma camera. Lancet (1970) 2.08
Indices of thyroid function in thyrotoxicosis. Lancet (1971) 1.83
Wheat fibre and irritable bowel syndrome. A controlled trial. Lancet (1977) 1.80
The late results of medical and surgical treatment for bleeding duodenal ulcer. Q J Med (1970) 1.70
Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther (2011) 1.59
Multifocal gastric carcinoid tumours, achlorhydria, and hypergastrinaemia. Lancet (1985) 1.48
A radioimmunoassay for cholecystokinin-pancreozymin. Lancet (1973) 1.33
Saline purgatives act by releasing cholecystokinin. Lancet (1973) 1.15
Preparation of prereduced anaerobically sterilized media and their use in cultivation of anaerobic bacteria. J Clin Microbiol (1978) 1.13
Changes in certain blood constituents during Ramadan. Am J Clin Nutr (1982) 1.09
Measuring Crohn's disease activity. Lancet (1980) 1.09
Psychologic prediction of duration of inpatient spinal cord injury rehabilitation and performance of self-care. Arch Phys Med Rehabil (1983) 1.07
Radioimmunoassay of cholecystokinin-pancreozymin. Gut (1974) 1.06
Applying psychometric criteria to functional assessment in medical rehabilitation: II. Defining interval measures. Arch Phys Med Rehabil (1992) 1.05
Intracellular messenger role of cyclic GMP in exocrine pancreas. Nature (1976) 1.05
Breakfast and Crohn's disease--II. Br Med J (1978) 1.03
Improving the diagnosis of coeliac disease in anaemic women. Br J Haematol (2000) 1.03
Applying psychometric criteria to functional assessment in medical rehabilitation: I. Exploring unidimensionality. Arch Phys Med Rehabil (1991) 1.01
Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis. Aliment Pharmacol Ther (2003) 0.99
Colonic motility in proctalgia fugax. Lancet (1979) 0.98
Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations. Gut (1990) 0.96
Psychiatric disorders in patients with spinal cord injuries. Arch Gen Psychiatry (1981) 0.96
Effects of cholecystokinin on colonic motility and symptoms in patients with the irritable bowel syndrome. Gut (1972) 0.95
Radioimmunoassay of lactoferrin in pancreatic juice as a test for pancreatic diseases. Lancet (1978) 0.94
Functional performance assessment: a program approach. Arch Phys Med Rehabil (1981) 0.93
Relationship between changes in plasma gastrin and lower oesophageal sphincter pressure after meals. Br J Surg (1975) 0.92
Spontaneous resolution of multifocal gastric enterochromaffin-like cell carcinoid tumours. Lancet (1988) 0.90
Iron-deficiency anaemia in premenopausal women. Lancet (1999) 0.90
Abnormalities of serum cholecystokinin and gallbladder emptying in celiac disease. N Engl J Med (1975) 0.89
Proceedings: Studies on the nature of cholecystokininpancreozymin in small-intestinal mucosal extracts. Gut (1974) 0.88
Chondroitin sulfatase--producing and hyaluronidase--producing oral bacteria associated with periodontal disease. J Can Dent Assoc (1982) 0.88
Rehabits: a common language of functional assessment. Arch Phys Med Rehabil (1995) 0.87
Bowel habit in thyrotoxicosis and hypothyroidism. Br Med J (1971) 0.87
Heterogeneity of DNA methylation in murine L5178Y lymphoblasts. Experientia (1979) 0.86
Functional abilities and distress levels in brain injured patients at long-term follow-up. Arch Phys Med Rehabil (1982) 0.86
Use of fluorescence microscopy for monitoring periodontal disease state. Can J Microbiol (1981) 0.85
Dreaming during scientific papers: effects of added extrinsic material. Br Med J (Clin Res Ed) (1984) 0.85
Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet (1977) 0.85
Risk factors for death and emergency transfer in acute and subacute inpatient rehabilitation. Arch Phys Med Rehabil (1996) 0.85
Hormonal content and effect on gallbladder of commercial preparations of cholecystokinin-pancreozymin. Horm Metab Res (1981) 0.84
Oxygen saturation during sleep in patients with spinal cord injury. Am J Phys Med (1982) 0.84
Modification by caffeine of acute cytotoxic response of cultured L5178Y cells to hydroxyurea treatment. Neoplasma (1987) 0.84
[An interesting case of eye injury]. Cesk Oftalmol (1978) 0.84
Abdominal and thoracic pressures during defaecation. Br Med J (1979) 0.83
Trypsin and lactoferrin levels in pure pancreatic juice in patients with pancreatic disease. Gut (1979) 0.83
Effects of oral magnesium sulphate on colonic motility in patients with the irritable bowel syndrome. Gut (1973) 0.83
The diagnosis of intra-abdominal abscesses in patients with severe Crohn's disease. Q J Med (1992) 0.82
Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjögren's syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol (2008) 0.81
Serum-thyroxine and thyroxine-binding globulin in seriously ill patients. Lancet (1971) 0.81
Drugs and thyroid-function tests. Br Med J (1967) 0.81
Relationship between changes of serum cholecystokinin-pancreozymin and serum insulin after different stimuli. Diabetologia (1975) 0.81
Effect of metiamide on basal and stimulated serum cholecystokinin levels in duodenal ulcer patients. Gut (1976) 0.80
Thyroxine "addicts". Br Med J (1973) 0.80
Depression in spinal cord injured patients. Paraplegia (1981) 0.80
Hormonal control of gastrointestinal motility. Am J Dig Dis (1975) 0.80
Ocular surface injuries in autoimmune dry eye. The severity of microscopical disturbances goes parallel with the severity of symptoms of dryness. Histol Histopathol (2009) 0.80
Neuropsychological assessment of schizophrenia versus brain damage: a review. J Nerv Ment Dis (1978) 0.80
Dyshormonogenetic goitre with high circulating levels of thyroid-stimulating hormone. Proc R Soc Med (1971) 0.80
The irritable bowel syndrome. Part III: hormonal influences. Clin Gastroenterol (1977) 0.79
Rehabilitation of memory after craniocerebral trauma: case report. Arch Phys Med Rehabil (1983) 0.79
Computerized tomography head scans as predictors of functional outcome of stroke patients. Arch Phys Med Rehabil (1988) 0.79
Results of a token economy. Arch Gen Psychiatry (1978) 0.79
Bacteroides species and gelatinase-producers in periodontal disease. J Can Dent Assoc (1982) 0.79
Current perceptions of rehabilitation professionals towards mild traumatic brain injury. Arch Phys Med Rehabil (1993) 0.79
Accidental hypothermia in erythroderma from generalized psoriasis. Arch Dermatol (1968) 0.79
Effect of hydroxyurea treatment on lysosomal membrane stability and enzyme latency in L5178Y cells in culture. Neoplasma (1986) 0.79
Hydroxyurea has the capacity to induce damage to human erythrocytes which can be modified by radical scavengers. Biochem Biophys Res Commun (1984) 0.78
Serum trypsin as measure of pancreatic exocrine function in children with protein calorie malnutrition. Lancet (1980) 0.78
Vocational/educational services in a medical rehabilitation facility: outcomes in spinal cord and brain injured patients. Arch Phys Med Rehabil (1982) 0.78
Effects of oral magnesium sulphate on colonic motility. Gut (1973) 0.77
Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjögren's syndrome). Nitric Oxide (2007) 0.77
Cancer rehabilitation. An analysis of 36 program approaches. JAMA (1982) 0.77
Pathogenesis of the impaired gall bladder contraction of coeliac disease. Gut (1987) 0.76
Comparison of the effect of hydroxyurea and methotrexate on DNA fragmentation at various reaction conditions. Neoplasma (1991) 0.76
The effect of substance P on cyclic AMP and cyclic GMP levels in actively secreting pancreatic lobules [proceedings]. J Physiol (1978) 0.76
Effect of coffee on human lower oesophageal function. Digestion (1981) 0.76
Grades of hypothyroidism. Br Med J (1973) 0.75
Gastric ECL cell hyperplasia. Gut (1987) 0.75
The knee-elbow position relieves distension. Gut (1994) 0.75
The role of conjunctival epithelial cell xanthine oxidoreductase/xanthine oxidase in oxidative reactions on the ocular surface of dry eye patients with Sjögren's syndrome. Histol Histopathol (2007) 0.75
Colonoscopy first for iron-deficiency anaemia. QJM (2007) 0.75
Protection against hydroxyurea-induced cytotoxic effects in L5178Y cells by free radical scavengers. Cancer Lett (1983) 0.75
Gut peptides and the control of food intake. Br Med J (Clin Res Ed) (1983) 0.75
Crohn's disease presenting as recurrent pulmonary oedema. Br Med J (Clin Res Ed) (1981) 0.75
Inhibition of leucocyte migration by cancer chemotherapeutic agents and its prevention by free radical scavengers and thiols. Eur J Haematol (1988) 0.75
[The 70th anniversary of Professor Emil Dienstbier, D.Sc]. Cesk Oftalmol (1978) 0.75
[Disorder in color perception--a primary sign of optic-nerve inflammation]. Cesk Oftalmol (1978) 0.75
Mechanism of unbalanced growth-induced cell damage. II. A probable relationship between unbalanced growth, DNA breakage and cell death. Chem Biol Interact (1986) 0.75
Hydroxyurea, methotrexate and adriblastine can mediate non-enzymatic reduction of nitroblue tetrazolium with NADH which is inhibited by superoxide dismutase. Biochem Pharmacol (1987) 0.75
Protection of L5178Y cells by vitamin E against acute hydroxyurea toxicity does not change the efficiency of ribonucleotide reductase-mediated hydroxyurea-induced cytotoxic events. Cancer Lett (1987) 0.75
Synchronization of L5178Y cells by treatment with hydroxyurea. Arch Immunol Ther Exp (Warsz) (1975) 0.75
[Use of vitamins E and C for the prevention of toxic effects of lead on electronic industry workers]. Wiad Lek (1988) 0.75
Enhancement of methotrexate-induced growth inhibition, cell killing and DNA lesions in cultured L5178Y cells by the reduction of DNA repair efficiency. Biochem Pharmacol (1989) 0.75
Biofeedback-assisted EMG reduction and subsequent self-disclosure. J Clin Psychol (1978) 0.75